TAK-041

CAS No. 1929519-13-0

TAK-041( NBI-1065846 )

Catalog No. M28601 CAS No. 1929519-13-0

TAK-041 is a potent and selective GPR139 agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 In Stock
10MG 430 In Stock
25MG 710 In Stock
50MG 972 In Stock
100MG 1341 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TAK-041
  • Note
    Research use only, not for human use.
  • Brief Description
    TAK-041 is a potent and selective GPR139 agonist.
  • Description
    TAK-041 is a potent and selective GPR139 agonist.
  • In Vitro
    ——
  • In Vivo
    Animal Model:BALB/c mice Dosage:0.03, 0.3, and 3 mg/kg Administration:P.o.Result:Dose-dependently improved the social behavior of BALB/c mice.
  • Synonyms
    NBI-1065846
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    PDE5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1929519-13-0
  • Formula Weight
    392.33
  • Molecular Formula
    C18H15F3N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (254.89 mM)
  • SMILES
    C[C@@H](c(cc1)ccc1OC(F)(F)F)NC(CN1N=Nc(cccc2)c2C1=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wolf-Georg Forssmann, et al. Use of phosphodiesterase inhibitors in the treatment of prostatic diseases. US 8106061 B2
molnova catalog
related products
  • BigLEN (mouse)

    GPR171 agonist. ProSAAS-derived neuropeptide. Regulates food intake in mice. Inhibits the release of glutamate onto parvocellular neurons of the paraventricular nucleus in a process dependent upon activation of postsynaptic G proteins.

  • SR-4370

    SR-?4370 is an HDAC inhibitor. SR-?4370 exhibited IC50 values of 0.5 μM, 0.1 μM and 0.06 μM towards HDAC1, HDAC2 and HDAC3.

  • hGPR91 antagonist 3

    hGPR91 antagonist 3 is an orally active, potent, and selective hGPR91 antagonist. hGPR91 antagonist 3 is used to study hypertension, autoimmune diseases, and retinal angiogenesis.